Dergiler / Turkish Journal of Medical Sciences / 2019 / Cilt: 49 - Sayı: 4

The association between levels of inflammatory markers in autistic children compared to their unaffected siblings and unrelated healthy controls

Sayfa
1047–1053
DOI
—

Abstract

Background/aim: Autism spectrum disorder (ASD) describes a range of neurodevelopmental disabilities that impair behavior andcommunication. Although it is relatively prevalent, the pathophysiology is still subject to speculation and debate. The aim of this studyis to identify a possible association between interleukin-6, -8, -9, and -10 and tumor necrosis factor alpha (TNF-α) in autism amongJordanian children by comparing the plasma levels of these cytokines in autistic children with those of their unaffected siblings andunrelated healthy controls.Materials and methods: In this study, 80 Jordanian children under the age of 12 with diagnosed autism were selected. For comparison,51 unaffected siblings and 86 unrelated healthy controls were also recruited. Venous blood was collected and interleukin levels in allthree groups were investigated.Results: Interleukin-6 was found to be significantly higher in the plasma of both autistic children and their siblings compared withthe unrelated healthy control group (P < 0.05). As for interleukin-8 and TNF-α, plasma levels were significantly higher exclusively inautistic children compared to their siblings and unaffected control subjects (P < 0.001, P < 0.001). There was no significant differencebetween plasma levels of the previously mentioned cytokines in the siblings and the unrelated control group. As for interleukin-9 andinterleukin-10, no significant differences were found between all three groups (P = 0.15, P = 0.35).Conclusion: We found that interleukin-8 and TNF-α were exclusively elevated in autistic Jordanian children, while interleukin-6was elevated in both autistic children and their siblings, potentially dismissing its significance. These results may lead to a betterunderstanding of the disorder’s pathophysiology, early testing, and diagnosis.